Methadone vs. Suboxone

What's the Difference?

Methadone and Suboxone are both medications used in the treatment of opioid addiction, but they have some key differences. Methadone is a full opioid agonist, meaning it activates the same receptors in the brain as other opioids, providing relief from withdrawal symptoms and cravings. It has a long half-life and is typically administered daily at specialized clinics. On the other hand, Suboxone is a partial opioid agonist, containing both buprenorphine and naloxone. Buprenorphine activates the opioid receptors to a lesser extent, reducing withdrawal symptoms and cravings, while naloxone blocks the effects of other opioids, discouraging misuse. Suboxone is usually prescribed by healthcare providers and can be taken at home. Both medications have their benefits and considerations, and the choice between them depends on individual needs and preferences.


Drug ClassOpioid agonistPartial opioid agonist
UsageTreatment for opioid addiction and pain managementTreatment for opioid addiction
AdministrationOralSublingual (under the tongue)
Duration of Action24-36 hours24-60 hours
Withdrawal SymptomsCan cause withdrawal symptoms if stopped abruptlyCan cause withdrawal symptoms if stopped abruptly
Side EffectsConstipation, drowsiness, sweating, nauseaHeadache, nausea, constipation, insomnia
EffectivenessEffective in reducing opioid cravings and withdrawal symptomsEffective in reducing opioid cravings and withdrawal symptoms
RegulationHighly regulated, often dispensed through specialized clinicsRegulated, can be prescribed by qualified healthcare providers

Further Detail


Methadone and Suboxone are two commonly prescribed medications used in the treatment of opioid addiction. Both medications are classified as opioid agonists, meaning they bind to the same receptors in the brain as opioids, but with different properties and effects. In this article, we will explore the attributes of Methadone and Suboxone, including their mechanism of action, effectiveness, side effects, and considerations for use.

Mechanism of Action

Methadone is a full opioid agonist, which means it activates the opioid receptors in the brain fully. It works by blocking the euphoric effects of other opioids, reducing cravings, and preventing withdrawal symptoms. Suboxone, on the other hand, is a partial opioid agonist. It contains buprenorphine, which also binds to the opioid receptors but with less intensity compared to methadone. Additionally, Suboxone contains naloxone, an opioid antagonist that blocks the effects of other opioids and discourages misuse.


Both Methadone and Suboxone have been proven effective in the treatment of opioid addiction. Methadone has been used for decades and has a long track record of success. It has been shown to reduce illicit opioid use, decrease criminal activity, and improve overall quality of life for individuals in treatment. Suboxone, although a relatively newer medication, has also demonstrated effectiveness in reducing opioid use and promoting recovery. Studies have shown that both medications can help individuals stay engaged in treatment and reduce the risk of relapse.

Side Effects

Like any medication, Methadone and Suboxone can cause side effects. Methadone may cause drowsiness, constipation, dry mouth, and sweating. It can also lead to respiratory depression if taken in high doses or combined with other central nervous system depressants. Suboxone, on the other hand, may cause headaches, nausea, insomnia, and sweating. It is important to note that the side effects of both medications are generally mild and well-tolerated, but individuals may experience different reactions based on their unique physiology.

Considerations for Use

When considering the use of Methadone or Suboxone, several factors should be taken into account. Methadone is typically administered in specialized clinics, requiring daily visits for medication dispensing. This can be a barrier for individuals who live far from a clinic or have limited transportation options. Suboxone, on the other hand, can be prescribed by qualified healthcare providers in an office-based setting, allowing for more flexibility and convenience. Additionally, Methadone has a higher risk of overdose compared to Suboxone, especially during the initial stages of treatment.

Another consideration is the potential for diversion and misuse. Methadone, due to its full agonist properties, carries a higher risk of diversion and abuse. It is tightly regulated and dispensed in controlled settings to minimize the risk. Suboxone, with its partial agonist and antagonist properties, has a lower risk of diversion and is less likely to be misused.


In conclusion, both Methadone and Suboxone are valuable medications in the treatment of opioid addiction. Methadone, as a full opioid agonist, has a long history of effectiveness but requires daily visits to specialized clinics. Suboxone, a partial agonist with an antagonist component, offers more flexibility and convenience with a lower risk of diversion. The choice between the two medications depends on individual circumstances, preferences, and the guidance of healthcare professionals. Ultimately, the goal is to find the most suitable treatment option that promotes recovery and helps individuals regain control of their lives.

Comparisons may contain inaccurate information about people, places, or facts. Please report any issues.